James Nisco's most recent trade in Lisata Therapeutics Inc was a trade of 15,000 Common Stock done . Disclosure was reported to the exchange on Jan. 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lisata Therapeutics Inc | James Nisco | SVP, Fin/Treas, Chief Actg Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 15,000 | 27,956 (0%) | 0% | 0 | Common Stock | |
| Lisata Therapeutics Inc | James Nisco | SVP, Fin/Treas, Chief Actg Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 7,000 | 7,000 | - | - | Stock Option (Right to Buy) | |
| Lisata Therapeutics Inc | James Nisco | SVP, Fin/Treas, Chief Actg Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.80 per share. | 09 Jan 2025 | 2,131 | 25,825 (0%) | 0% | 3.8 | 8,098 | Common Stock |
| Lisata Therapeutics Inc | James Nisco | SVP, Fin/Treas, Chief Actg Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.80 per share. | 09 Jan 2025 | 1,137 | 24,688 (0%) | 0% | 3.8 | 4,321 | Common Stock |
| Lisata Therapeutics Inc | James Nisco | SVP, Fin/Treas, Chief Actg Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.80 per share. | 09 Jan 2025 | 781 | 23,907 (0%) | 0% | 3.8 | 2,968 | Common Stock |
| Lisata Therapeutics Inc | James Nisco | SVP, Fin/Treas, Chief Actg Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.73 per share. | 09 Jan 2025 | 416 | 23,491 (0%) | 0% | 3.7 | 1,552 | Common Stock |
| Lisata Therapeutics Inc | James Nisco | SVP, Fin/Treas, Chief Actg Off | Grant, award, or other acquisition of securities at price $ 2.93 per share. | 01 Oct 2024 | 3,300 | 14,657 (0%) | 0% | 2.9 | 9,669 | Common Stock |
| Lisata Therapeutics Inc | James Nisco | SVP, Fin/Treas, Chief Actg Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. | 01 Oct 2024 | 1,701 | 12,956 (0%) | 0% | 2.9 | 4,984 | Common Stock |